InvestmentJul 31, 2026, 09:04 AM
NewcelX Raises $1.4M via Private Placement at 20% Premium
AI Summary
NewcelX Ltd. announced a private placement of 347,134 common shares at $4.033 per share, representing a 20% premium to its last closing price. The offering also includes warrants to purchase an equal number of shares at an exercise price of $4.437 per share. Participation from existing shareholders and new investors reflects confidence in the company's strategy and its lead program, NCEL-101. The company intends to use the net proceeds to advance NCEL-101 towards IND-enabling studies and for general corporate purposes, with the closing expected around August 14, 2026.
Key Highlights
- NewcelX entered into securities purchase agreements for a private placement.
- The offering is for 347,134 common shares at $4.033 per share.
- The purchase price represents a 20% premium to the last closing price.
- Warrants to purchase 347,134 common shares are included, with an exercise price of $4.437 per share.
- The exercise price is 132% of the last closing price.
- Existing shareholders and new long-term investors are participating in the offering.
- Net proceeds will primarily advance NCEL-101, the lead program for type 1 diabetes.
- The offering is expected to close on or about August 14, 2026.
Price Impact
More from NCEL